Alcon Inc. (FRA:2U3)

Market Cap	33.47B -15.9%
Revenue (ttm)	8.68B +4.3%
Net Income	892.36M -9.8%
EPS	1.79 -10.2%
Shares Out	n/a
PE Ratio	37.51
Forward PE	24.45
Dividend	0.30 (0.44%)
Ex-Dividend Date	May 13, 2025

Volume	11,652
Average Volume	195
Open	52.91
Previous Close	52.88
Day's Range	52.91 - 54.40
52-Week Range	54.07 - 85.74
Beta	n/a
RSI	49.60
Earnings Date	Feb 24, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Ophthalmic Goods
• Founded: 1945
• Employees: 25,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2U3

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD